- Post-Effective Amendment to an S-8 filing (S-8 POS)
24 Febrero 2011 - 2:51PM
Edgar (US Regulatory)
As filed with the Securities and Exchange Commission on February 24, 2011
Registration Statement No. 333-143740
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-143740
UNDER THE SECURITIES ACT OF 1933
BMP SUNSTONE CORPORATION
(Exact Name of Registrant as Specified in Its
Charter)
|
|
|
Delaware
|
|
20-0434726
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(I.R.S. Employer
Identification No.)
|
600 W. Germantown Pike Suite 400
Plymouth Meeting, PA 19462 (610) 940-1675
(Address, Including Zip Code, and Telephone Number, including Area Code, of Registrants Principal Executive Offices)
BEIJING MED-PHARM CORPORATION
2007 OMNIBUS EQUITY COMPENSATION PLAN
(Full Title of the Plans)
David Gao
President and Chief Executive Officer
BMP Sunstone Corporation
600 W. Germantown Pike
Suite 400
Plymouth Meeting, PA 19462
(610) 940-1675
(Name, Address, Including Zip Code, and Telephone
Number, Including Area Code, of Agent for Service)
Copies to:
Joanne R. Soslow, Esq.
Morgan, Lewis & Bockius LLP
1701 Market Street
Philadelphia, Pennsylvania 19103
(215) 963-5000
Indicate by
check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and
smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated filer
¨
|
|
Accelerated filer
þ
|
|
Non-accelerated filer
¨
|
|
Smaller reporting company
¨
|
|
|
|
|
(Do not check if a smaller reporting company)
|
DEREGISTRATION OF SECURITIES
This Post-Effective Amendment (this Post-Effective Amendment) filed by BMP Sunstone Corporation, a Delaware corporation (the
Company), removes from registration all shares of common stock, par value $0.001 (Common Stock), of the Company registered under the Registration Statement on Form S-8 (the Registration Statement) filed by the
Company with the U.S. Securities and Exchange Commission (the Commission) on June 14, 2007, pertaining to the registration of shares of Common Stock offered under the 2007 Omnibus Equity Compensation Plan (the Plan).
On October 28, 2010, the Company entered into an Agreement and Plan of Merger with sanofi-aventis, a French
société anonyme
(Parent), and Star 2010, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (Merger Sub), providing for, among other things, the merger of Merger Sub with and into the
Company (the Merger), with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent. The Merger is effective as of February 24, 2011 (the Effective Time), pursuant to a Certificate of
Merger filed with the Secretary of State of the State of Delaware.
At the Effective Time, each outstanding share of Common
Stock (other than shares owned by the Company or its subsidiaries, Parent or Merger Sub) was automatically converted into the right to receive $10.00 in cash, without interest and less any applicable withholding taxes.
As a result of the Merger, the Company has terminated the Plan and all offerings of it securities pursuant to its existing registration
statements, including the Registration Statement. In accordance with an undertaking made by the Company in the Registration Statement to remove from registration, by means of a posteffective amendment, any securities which remain unsold at the
termination of the offering, the Company hereby removes from registration all securities registered under the Registration Statement which remained unsold as of the date of this Post-Effective Amendment and terminates the effectiveness of the
Registration Statement.
ITEM 16.
|
EXHIBITS AND FINANCIAL SCHEDULES.
|
|
|
|
Exhibit
Number
|
|
Description
|
|
|
24.01
|
|
Power of Attorney (previously filed)
|
2
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8
and has duly caused this Post-Effective Amendment No. 1 to be signed on its behalf by the undersigned, thereunto duly authorized, in Plymouth Meeting, in the Commonwealth of Pennsylvania, on February 24, 2011.
|
|
|
BMP SUNSTONE CORPORATION
|
|
|
By:
|
|
/s/ Fred M. Powell
|
|
|
Name: Fred M. Powell
Title: Chief Financial Officer
|
3
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, this Post-Effective Amendment has been signed by the following persons in the capacities and on the dates indicated.
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
/s/ David Gao
David Gao
|
|
President, Chief Executive Officer and Director
(Principal Executive Officer)
|
|
February 24, 2011
|
|
|
|
/s/ Fred M. Powell
Fred M. Powell
|
|
Chief Financial Officer (
Principal Financial and Accounting Officer
)
|
|
February 24, 2011
|
|
|
|
*
Martyn D. Greenacre
|
|
Chairman
|
|
February 24, 2011
|
|
|
|
*
Les R. Baledge
|
|
Director
|
|
February 24, 2011
|
|
|
|
*
Daniel P. Harrington
|
|
Director
|
|
February 24, 2011
|
|
|
|
*
Frank J. Hollendoner
|
|
Director
|
|
February 24, 2011
|
|
|
|
*
John W. Stakes, M.D.
|
|
Director
|
|
February 24, 2011
|
|
|
|
*
Zhijun Tong
|
|
Director
|
|
February 24, 2011
|
|
|
|
*
Albert Yeung
|
|
Director
|
|
February 24, 2011
|
|
|
|
|
|
*By:
|
|
/s/ Fred M. Powell
|
|
|
Fred M. Powell
Attorney-in-fact
|
4
Exhibit index
|
|
|
Exhibit
Number
|
|
Description
|
|
|
24.01
|
|
Power of Attorney (previously filed)
|
5
Bmp Sunstone Corp. (MM) (NASDAQ:BJGP)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Bmp Sunstone Corp. (MM) (NASDAQ:BJGP)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024